Apogee Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.2M | 31k | 39.73 |
| 2025-06-30 | $2.4M | 55k | 43.43 |
| 2025-03-31 | $1.3M | 36k | 37.36 |
| 2024-12-31 | $1.5M | 32k | 45.30 |
| 2024-09-30 | $1.9M | 32k | 58.74 |
| 2024-06-30 | $1.4M | 34k | 39.35 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas